Category: Regulatory DisclosuresBy adminMarch 24, 2024 Author: admin https://ramedapharma-ir.com Post navigationPreviousPrevious post:Rameda 4Q23 Earnings ReleaseNextNext post:The invitation to shareholders for the AGMRelated PostsRameda Announces New Chairman and Additions to its Board of DirectorsJune 3, 2026Rameda Initiates First Acquisition of 2025July 7, 2025Record Dividend Distribution DisclosureJuly 7, 2025BOD-Shareholding-Structure-2024April 15, 2024The invitation to shareholders for the AGMMarch 31, 2024Rameda 4Q23 BOD Meeting MinutesMarch 18, 2024
